Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bachelerie

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annales De Dermatologie Et De Venereologie|June 25, 2019
[Erythroderma revealing IPEX syndrome]M Bachelerie, E Merlin, F Beltzung, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 24, 2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)J Zitouni, A-C Bursztejn, A Belloni Fortina, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annales De Dermatologie Et De Venereologie|June 25, 2019
[Erythroderma revealing IPEX syndrome]M Bachelerie, E Merlin, F Beltzung, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 24, 2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)J Zitouni, A-C Bursztejn, A Belloni Fortina, et al.
Pageof 1